Skip to main content
Caplight Logo









Shanghai New Pulse Medical Technology

Shanghai New Pulse Medical Technology

Private
ShanghaiHealthcare & Life Scienceshttps://newmed.cn/

Last Round

Series C

Mar 25, 2021

Est. Valuation

$713M

Total Funding Raised

$136.21M

Company Overview

Shanghai New Pulse Medical Technology is a medical device company that specializes in the research, development, and industrialization of artificial heart valves and transcatheter implantation systems.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

transcatheter heart valveballoon-expandable valveinterventional cardiologyminimally invasive surgeryTAVRmedical device manufacturercardiovascular medical deviceheart valve replacementcatheter delivery systeminterventional toolsmedtechvalve repair

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Shanghai New Pulse Medical Technology Comparables

Compare Shanghai New Pulse Medical Technology with similar companies based on industry and business-model similarity.

Shanghai New Pulse Medical Technology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MITRASSIST LIFESCIENCES LIMITED
88%
MicroPort Scientific
86%
Peijia Medical
83%

Shanghai New Pulse Medical Technology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMar 25, 2021
Series B ExtensionApr 15, 2020
Series BMar 3, 2020
Series A ExtensionJul 1, 2018
Series AApr 4, 2018
Pre Seed
Jan 1, 2016

Shanghai New Pulse Medical Technology Investors

Notable investors and investment history

Shanghai New Pulse Medical Technology investors
InvestorRounds
BioTrack CapitalSeries C
TemasekSeries C
Boyuan CapitalSeries C
LYFE CapitalSeries A
CBC GroupSeries C
OrbiMedSeries C, Series B Extension, Series B
Shenzhen Dachen Caizhi Venture Capital ManagementSeries C, Series B Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Pipeline includes TMVR and ventricular assist products.

  • Mar 1, 2026

    Obtained 9 certificates for valve systems and accessory products.

Shanghai New Pulse Medical Technology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Shanghai New Pulse Medical Technology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Shanghai New Pulse Medical Technology's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range7
Year Founded2015
Last FundingMar 25, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?